Earnings History Data for ReShape Lifesciences, Inc. (RSLS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
ReShape Lifesciences, Inc.
ReShape Lifesciences Inc. provides weight-loss solutions. It offers an integrated portfolio of proven products and services which manage and treat obesity and metabolic disease. ReShape Lifesciences Inc., formerly known as Obalon Therapeutics, is based in SAN CLEMENTE, CA.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15-05-2024 | AH | RSLS | ReShape Lifesciences, Inc. | 3.92 | -0.09 | 0.00 | -1.56 | ReShape Lifesciences reports Q1 results [5/15/2024 5:02 PM] |
0.1712 | 0.0 (-1.61%) |
0.17 | 0.0 (-2.36%) |
0.14 - 2.76 | 458,461 | 190,000 | 10,516 | ||
| 08-11-2023 | AH | RSLS | ReShape Lifesciences, Inc. | 0.82 | -1.02 | 0.00 | -10.50 | ReShape Lifesciences reports Q3 results [11/8/2023 5:45 PM] |
0.2346 | -0.02 (-7.60%) |
0.24 | -0.01 (-5.47%) |
0.19 - 22.40 | 1,238,862 | 1,780,000 | 76,809 | ||
| 15-05-2023 | AH | After the close (May 15) |
RSLS | ReShape Lifesciences, Inc. | 4.32 | -1.56 | 0.00 | 21.00 | ReShape Lifesciences reports Q1 results [5/15/2023 4:20 PM] |
2.30 | -0.16 (-6.50%) |
2.43 | -0.03 (-1.22%) |
2.21 - 52.50 | 75,270 | 100,000 | 2,965 | |
| 14-11-2022 | PM | 0:00 AM ET (Nov 14) |
RSLS | ReShape Lifesciences, Inc. | 3.50 | -0.21 | 0.00 | -1.20 | ReShape Lifesciences reports Q3 results [11/14/2022 7:37 AM] |
0.24 | 0.01 (3.18%) |
0.25 | 0.01 (6.19%) |
0.20 - 2.33 | 257,621 | 180,000 | 12,257 | |
| 23-05-2022 | PM | 0:00 AM ET (May 23) |
RSLS | ReShape Lifesciences, Inc. | 15.48 | -0.42 | 0.00 | -1.32 | ReShape Lifesciences GAAP EPS of -$0.44 misses by $0.10, revenue of $2.44M misses by $0.78M [5/23/2022 8:02 AM] |
0.8015 | -0.01 (-1.78%) |
0.81 | -0.01 (-0.74%) |
0.65 - 14.64 | 39,520 | 70,000 | 4,884 | |
| 28-03-2022 | AH | 0:00 AM ET (Mar 28) |
RSLS | ReShape Lifesciences, Inc. | 20.28 | 0.05 | 0.00 | -0.51 | ReShape Lifesciences GAAP EPS of $5.00, revenue of $13.69M [3/28/2022 4:11 PM] |
1.37 | 0.02 (1.33%) |
1.52 | 0.17 (12.59%) |
0.83 - 14.64 | 520,982 | 260,000 | 69,633 | |
| 11-11-2021 | PM | Before the open (Nov 11) |
RSLS | ReShape Lifesciences, Inc. | 42.30 | -1.20 | 0.00 | -0.60 | ReShape Lifesciences reports Q3 results [11/11/2021 8:54 AM] |
2.47 | -0.05 (-2.17%) |
2.52 | -0.01 (-0.40%) |
2.38 - 32.31 | 901,453 | 440,000 | 73,365 | |
| 05-08-2021 | PM | RSLS | ReShape Lifesciences, Inc. | 58.93 | N/A | 0.00 | -1.62 | ReShape Lifesciences reports Q2 results [8/5/2021 8:47 AM] |
3.85 | 0.25 (6.89%) |
3.99 | 0.39 (10.83%) |
2.13 - 32.31 | 3,878,720 | 3,240,000 | 2,082,133 | ||